At OpenBiome Foundation, we’re driven by a simple truth: groundbreaking therapies should reach the patients who need them most. Every day, we see the potential of microbiome-targeted therapies to change outcomes for people facing serious, often life-threatening conditions like Clostridioides difficile (C. diff).
We exist to accelerate that progress—by helping deliver today’s most promising treatments, while laying the groundwork for tomorrow’s breakthroughs.